Showing 1–43 of 43 results
-
Research |
Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study
- Laetitia Largeaud
- , Pascale Cornillet-Lefebvre
- , Jean-François Hamel
- , Pierre-Yves Dumas
- , Naïs Prade
- , Stéphanie Dufrechou
- , Julien Plenecassagnes
- , Isabelle Luquet
- , Odile Blanchet
- , Anne Banos
- , Marie C. Béné
- , Marc Bernard
- , Sarah Bertoli
- , Caroline Bonmati
- , Luc Matthieu Fornecker
- , Romain Guièze
- , Lamya Haddaoui
- , Mathilde Hunault
- , Jean Christophe Ianotto
- , Eric Jourdan
- , Mario Ojeda
- , Pierre Peterlin
- , Norbert Vey
- , Hacene Zerazhi
- , Hicheri Yosr
- , Ariane Mineur
- , Jean-Yves Cahn
- , Norbert Ifrah
- , Christian Récher
- , Arnaud Pigneux
- , Eric Delabesse
- , J.-P. Marolleau
- , A. Aleme
- , F. Orsini-Piocelle
- , N. Cadoux
- , N. Ifrah
- , M. Hunault
- , C. Marie
- , A. Al Jijakli
- , G. Lepeu
- , H. Zerazhi
- , M. Beyrne
- , A. Banos
- , S. Labarrere
- , E. Deconinck
- , M. Peria
- , A. El Yamani
- , O. Kadiri
- , B. Choufi
- , M. Brument
- , A. Pigneux
- , T. Leguay
- , P.-Y. Dumas
- , C. Berthou
- , G. Guillerm
- , G. Drugmanne
- , O. Tournilhac
- , G. Roy
- , B. Audhuy
- , S. Camara
- , D. Caillot
- , M. Grandjean
- , J.-Y. Cahn
- , C.-E. Bulabois
- , B. Fief
- , N. Vey
- , C. Ladraa
- , V. Dorvaux
- , M. Hagopian
- , N. Fegueux
- , C. Fenoll
- , V. Sabadash
- , M. Ojeda
- , C. Haby
- , F. Witz
- , C. Bonmati
- , M. Lhuire
- , J. Delaunay
- , P. Peterlin
- , L. Airiau
- , L. Mannone
- , I. Touitou
- , E. Jourdan
- , D. Umuhire
- , M. Alexis
- , O. Michel
- , F. Dreyfus
- , D. Bouscary
- , A. Cheung
- , L. Sanhes
- , F. Touhami
- , E. Ribas
- , M. Puyade
- , M.-P. Gallego-Hernanz
- , N. Hugon
- , C. Himberlin
- , L. Maggi
- , T. Lamy
- , A. Testu
- , E. Tavernier
- , S. Marchand
- , B. Lioure
- , C. Kravanja
- , L. Benboubker
- , D. Nollet
- , M. Attal
- , C. Recher
- , A. Sarry
- , A. Lhermitte
- , G. Yrica
- , D. Schwartz
- , N. Le Montagner
- , C. Fenoll
- , V. Sabadash
- , D. Nollet
- , L. Auvray
- , R. Delepine
- & A. Fayault
-
| Open
Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial
- M Hunault-Berger
- , N Maillard
- , C Himberlin
- , C Recher
- , A Schmidt-Tanguy
- , B Choufi
- , C Bonmati
- , M Carré
- , M-A Couturier
- , E Daguindau
- , J-P Marolleau
- , F Orsini-Piocelle
- , J Delaunay
- , E Tavernier
- , S Lissandre
- , M Ojeda-Uribe
- , L Sanhes
- , L Sutton
- , A Banos
- , L M Fornecker
- , M Bernard
- , D Bouscary
- , A Saad
- , M Puyade
- , V Rouillé
- , I Luquet
- , M C Béné
- , J-F Hamel
- , F Dreyfus
- , N Ifrah
- & A Pigneux
-
-
Research |
-
| Open
-
-
-
Correspondence |
-
-
-
Research |
-
-
Correspondence |
-
Research |
Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Société Française de Greffe de Moelle (SFGM)
- M Michallet
- , X Thomas
- , JP Vernant
- , M Kuentz
- , G Socié
- , H Espérou-Bourdeau
- , N Milpied
- , D Blaise
- , B Rio
- , J Reiffers
- , JP Jouet
- , JY Cahn
- , JH Bourhis
- , B Lioure
- , M Leporrier
- , JJ Sotto
- , G Souillet
- , L Sutton
- , P Bordigoni
- , F Dreyfus
- , H Tilly
- , N Gratecos
- , M Attal
- , PY Leprise
- , F Déméocq
- , G Michel
- , A Buzyn
- , B Delmas-Marsalet
- , F Bernaudin
- , N Ifrah
- , A Sadoun
- , D Guyotat
- , M Cavazzana-Cavo
- , D Caillot
- , T De Revel
- , JP Vannier
- , A Baruchel
- , N Fegueux
- , ML Tanguy
- , A Thiébaut
- , A Belhabri
- & E Archimbaud
Bone Marrow Transplantation 26 , 1157–1163 -
-
Correspondence |
-
Research |
-
-
-
Research |
Allogeneic stem cell transplantation improves the outcome of adults with t(1;19)/E2A-PBX1 and t(4;11)/MLL-AF4 positive B-cell acute lymphoblastic leukemia: results of the prospective multicenter LALA-94 study
- N Vey
- , X Thomas
- , C Picard
- , T Kovascovicz
- , C Charin
- , J M Cayuela
- , H Dombret
- , N Dastugue
- , F Huguet
- , C Bastard
- , A Stamatoulas
- , M Giollant
- , O Tournilhac
- , E Macintyre
- , A Buzyn
- , D Bories
- , M Kuentz
- , F Dreyfus
- , A Delannoy
- , S Raynaud
- , N Gratecos
- , D Bordessoule
- , S de Botton
- , C Preudhomme
- , O Reman
- , X Troussard
- , A Pigneux
- , C Bilhou
- , J P Vernant
- , C Boucheix
- & J Gabert
Leukemia 20 , 2155–2161 -
-
-
Correspondence |
-
-
Correspondence |
-
-
Research |
-
-
-
Correspondence |
-
Research |
Early allogeneic transplantation favorably influences the outcome of adult patients suffering from acute myeloid leukemia
- E Jourdan
- , D Maraninchi
- , J Reiffers
- , E Gluckman
- , B Rio
- , JP Jouet
- , M Michallet
- , L Molina
- , E Archimbaud
- , JL Harousseau
- , N Ifrah
- , M Attal
- , F Guilhot
- , M Kuentz
- , D Guyotat
- , JL Pico
- , C Dauriac
- , M Legros
- , F Dreyfus
- , P Bordigoni
- , V Leblond
- , N Gratecos
- , B Varet
- , C Auzanneau
- , H Tilly
- , E Vilmer
- , VJ Bardou
- & D Blaise
-
Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study
- F Lefrère
- , A Delmer
- , F Suzan
- , V Levy
- , C Belanger
- , M Djabarri
- , B Arnulf
- , G Damaj
- , N Maillard
- , V Ribrag
- , M Janvier
- , C Sebban
- , R-O Casasnovas
- , R Bouabdallah
- , F Dreyfus
- , V Verkarre
- , E Delabesse
- , F Valensi
- , E McIntyre
- , N Brousse
- , B Varet
- & O Hermine
Leukemia 16 , 587–593 -
Reviews |
-
Correspondence |
-
-
Research |
Lenalidomide with or without erythropoietin in transfusion-dependent erythropoiesis-stimulating agent-refractory lower-risk MDS without 5q deletion
- A Toma
- , O Kosmider
- , S Chevret
- , J Delaunay
- , A Stamatoullas
- , C Rose
- , O Beyne-Rauzy
- , A Banos
- , A Guerci-Bresler
- , S Wickenhauser
- , D Caillot
- , K Laribi
- , B De Renzis
- , D Bordessoule
- , C Gardin
- , B Slama
- , L Sanhes
- , B Gruson
- , P Cony-Makhoul
- , B Chouffi
- , C Salanoubat
- , R Benramdane
- , L Legros
- , E Wattel
- , G Tertian
- , K Bouabdallah
- , F Guilhot
- , A L Taksin
- , S Cheze
- , K Maloum
- , S Nimuboma
- , C Soussain
- , F Isnard
- , E Gyan
- , R Petit
- , J Lejeune
- , V Sardnal
- , A Renneville
- , C Preudhomme
- , M Fontenay
- , P Fenaux
- & F Dreyfus
-
Research |
Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM)
- M G Della Porta
- , H Tuechler
- , L Malcovati
- , J Schanz
- , G Sanz
- , G Garcia-Manero
- , F Solé
- , J M Bennett
- , D Bowen
- , P Fenaux
- , F Dreyfus
- , H Kantarjian
- , A Kuendgen
- , A Levis
- , J Cermak
- , C Fonatsch
- , M M Le Beau
- , M L Slovak
- , O Krieger
- , M Luebbert
- , J Maciejewski
- , S M M Magalhaes
- , Y Miyazaki
- , M Pfeilstöcker
- , M A Sekeres
- , W R Sperr
- , R Stauder
- , S Tauro
- , P Valent
- , T Vallespi
- , A A van de Loosdrecht
- , U Germing
- , D Haase
- , P L Greenberg
- & M Cazzola
Leukemia 29 , 1502–1513 -
Research |
High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial
- D Rossille
- , M Gressier
- , D Damotte
- , D Maucort-Boulch
- , C Pangault
- , G Semana
- , S Le Gouill
- , C Haioun
- , K Tarte
- , T Lamy
- , N Milpied
- , T Fest
- , G Damaj
- , A Clavert
- , A Al Jijakli
- , A Banos
- , J-L Dutel
- , E Deconinck
- , P Rodon
- , K Bouabdallah
- , P Soubeyran
- , B Choufi
- , A Maakaroun
- , O Tournilhac
- , J Fleury
- , R Gressin
- , H Maisonneuve
- , K Laribi
- , P Solal-Celigny
- , P Moreau
- , J-F Rossi
- , G Cartron
- , N Morineau
- , J L Harousseau
- , E Jourdan
- , M Alexis
- , F Dreyfus
- , V Delwail
- , J Cornillon
- , R Garidi
- , E Gyan
- , P Colombat
- & P Godemer
-
Research |
-
Research |
-
Research |
Granulocyte–macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial)
- X Thomas
- , P Fenaux
- , H Dombret
- , S Delair
- , F Dreyfus
- , H Tilly
- , A Vekhoff
- , P Cony-Makhoul
- , V Leblond
- , X Troussard
- , C Cordonnier
- , T de Revel
- , M Simon
- , F Nicolini
- , AM Stoppa
- , M Janvier
- , D Bordessoule
- , P Rousselot
- , M Ffrench
- , JP Marie
- & E Archimbaud
Leukemia 13 , 1214–1220 -
Research |
-
Research |
